DE289274C - - Google Patents
Info
- Publication number
- DE289274C DE289274C DENDAT289274D DE289274DA DE289274C DE 289274 C DE289274 C DE 289274C DE NDAT289274 D DENDAT289274 D DE NDAT289274D DE 289274D A DE289274D A DE 289274DA DE 289274 C DE289274 C DE 289274C
- Authority
- DE
- Germany
- Prior art keywords
- allyl
- norcodeine
- chloroform
- allyldihydronorcodeine
- dissolved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- HKOIXWVRNLGFOR-UHFFFAOYSA-N norcodeine Natural products O1C2C(O)C=CC3C4CC5=CC=C(OC)C1=C5C23CCN4 HKOIXWVRNLGFOR-UHFFFAOYSA-N 0.000 claims description 10
- 229950004392 norcodeine Drugs 0.000 claims description 9
- HKOIXWVRNLGFOR-KOFBORESSA-N norcodeine Chemical compound O[C@H]([C@@H]1O2)C=C[C@H]3[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4 HKOIXWVRNLGFOR-KOFBORESSA-N 0.000 claims description 5
- IKGNKASQBMZRJL-KOFBORESSA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-1,2,3,4,4a,5,6,7,7a,13-decahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol Chemical compound O[C@H]([C@@H]1O2)CC[C@H]3[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4 IKGNKASQBMZRJL-KOFBORESSA-N 0.000 claims description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 1
- 125000000018 nitroso group Chemical group N(=O)* 0.000 claims 1
- 229940099678 norco Drugs 0.000 claims 1
- 235000010288 sodium nitrite Nutrition 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- HFEHLDPGIKPNKL-UHFFFAOYSA-N allyl iodide Chemical compound ICC=C HFEHLDPGIKPNKL-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229930003347 Atropine Natural products 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical class [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE289274C true DE289274C (enrdf_load_stackoverflow) |
Family
ID=544317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT289274D Active DE289274C (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE289274C (enrdf_load_stackoverflow) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2741617A (en) * | 1953-02-05 | 1956-04-10 | Merck & Co Inc | N-substituted dihydronorcodeinone |
| US2741612A (en) * | 1956-04-10 | N-substttuted dffiybronormorphine | ||
| US2741609A (en) * | 1956-04-10 | N-chjchjchj | ||
| WO2009078988A1 (en) * | 2007-12-17 | 2009-06-25 | Mallinckrodt Inc. | Sinomenine derivatives and processes for their synthesis |
-
0
- DE DENDAT289274D patent/DE289274C/de active Active
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2741612A (en) * | 1956-04-10 | N-substttuted dffiybronormorphine | ||
| US2741609A (en) * | 1956-04-10 | N-chjchjchj | ||
| US2741617A (en) * | 1953-02-05 | 1956-04-10 | Merck & Co Inc | N-substituted dihydronorcodeinone |
| WO2009078988A1 (en) * | 2007-12-17 | 2009-06-25 | Mallinckrodt Inc. | Sinomenine derivatives and processes for their synthesis |
| US8461337B2 (en) | 2007-12-17 | 2013-06-11 | Mallinckrodt Llc | Sinomenine derivatives and processes for their synthesis |
| AU2008338970B2 (en) * | 2007-12-17 | 2013-08-22 | SpecGx LLC | Sinomenine derivatives and processes for their synthesis |
| US8614224B2 (en) | 2007-12-17 | 2013-12-24 | Mallinckrodt Llc | Sinomenine derivatives and processes for their synthesis |
| CN101896464B (zh) * | 2007-12-17 | 2014-12-10 | 马林克罗特有限公司 | 青藤碱衍生物和它们的合成方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE289274C (enrdf_load_stackoverflow) | ||
| DE1445153C3 (de) | l,2,3,4,5,6-Hexahydro-3-(3-methyl-2butenyl>6,ll-dimethyl-8-hydroxy-2,6methano-3-benzazocin, seine Säureadditionssalze und Verfahren zu ihrer Herstellung | |
| DE904289C (de) | Verfahren zur Herstellung hydrierter Verbindungen mit dem Formylpteroinsaeurekern | |
| DE937952C (de) | Verfahren zur Herstellung analeptisch wirksamer 2-Aminoindanverbindungen | |
| DE872947C (de) | Verfahren zur Herstellung basischer AEther, Thioaether und ihrer Salze | |
| DE1101428B (de) | Verfahren zur Herstellung langwirkender Aminobenzolsulfonsaeure-amidderivate | |
| AT112127B (de) | Verfahren zur Darstellung von halogenhaltigen Pyridinderivaten. | |
| DE936571C (de) | Verfahren zur Herstellung von 4-Aminochromanen | |
| DE267082C (enrdf_load_stackoverflow) | ||
| DE954155C (de) | Verfahren zur Herstellung von 4-Aminochromanen | |
| DE613123C (de) | Verfahren zur Darstellung von Hydrierten Benzoisotetrazolen | |
| AT226888B (de) | Verfahren zur Herstellung von Nordihydrotoxiferin und dessen Quaternisierungsprodukten | |
| DE946800C (de) | Verfahren zur Herstellung therapeutisch wertvoller 1-substituierter 2-Aminomethylindanole-(3) | |
| AT269172B (de) | Verfahren zur Herstellung von neuen basisch substituierten Alkylxanthinderivaten | |
| DE829595C (de) | Verfahren zur Herstellung von Adenosin-5-triphosphorsaeure | |
| DE1189074B (de) | Verfahren zur Herstellung von 3-Aminoverbindungen der Androstan- bzw. Pregnan-Reihe | |
| DE1943777A1 (de) | Neue Amino-propiophenone | |
| DE670683C (de) | Verfahren zur Herstellung von in 1-Stellung einen hydroaromatischen oder teilweise hydrierten aromatischen Rest tragenden Isochinolinverbindungen und deren im Pyridinring ganz oder teilweise hydrierten Derivaten | |
| AT257571B (de) | Verfahren zur Herstellung des neuen N-Benzyl-α,α-dimethyl-β-(p-fluorphenyl)-äthylamins und dessen Salze | |
| AT222123B (de) | Verfahren zur Herstellung neuer 2-(p-Aminobenzolsulfonamido)-5-alkoxypyrimidine | |
| DE240793C (enrdf_load_stackoverflow) | ||
| DE188435C (enrdf_load_stackoverflow) | ||
| DE1173093B (de) | Verfahren zur Herstellung von 3ª-Amino-11-keto-20, 20-bis-hydroxymethyl-5ª-pregnanbzw. von Salzen desselben | |
| CH256347A (de) | Verfahren zur Herstellung eines Antiepileptikums. | |
| DE1134075B (de) | Verfahren zur Herstellung von primaeren Steroid-21-orthophosphorsaeureestern und deren physiologisch vertraeglichen wasserloeslichen Salzen |